top of page
Latest News
A recent study shows a surprising improvement in respiratory outcomes when patients with asthma receive weight loss drugs.
Singapore, [10 April 2025] – A large real world evidence study conducted by leading respiratory experts found patients with asthma who...
Apr 82 min read
Innovative analysis predicts steroid-related health risks for people with asthma
Singapore, [8 April 2025] – Groundbreaking research by the Observational and Pragmatic Research Institute (OPRI) has developed...
Apr 82 min read
Ground-breaking new study from ISAR uncovers the power of asthma tests BEC and FeNO to predict effectiveness of biologic therapies in Severe Asthma
A new real-world research study from ISAR, the International Severe Asthma Registry , reveals the strength of the asthma tests...
May 8, 20242 min read
New ISAR Research Sheds Light on Asthma Exacerbation Rates: Great Variability Found Across Nations
The International Severe Asthma Registry is a global collaborative initiative to gather anonymous, longitudinal, real-life data for...
Apr 25, 20241 min read
Thirty-year trends analysis reveals continuous overuse of systemic glucocorticoids to treat patients with asthma in the United Kingdom
Singapore, [19 April 2024] – Analysis of data from the Optimum Patient Care Research Database (OPCRD) has shown high rates of systemic...
Apr 19, 20242 min read
Blue reliever inhaler overuse strongly linked with increased asthma attacks: Critical findings revealed in new study from Optimum Patient Care Australia
The new publication ‘The association between short-acting β2-agonist over-prescription, and patient-reported acquisition and use on...
Apr 15, 20243 min read
New evidence reveals the power of biologics to improve severe asthma outcomes in patients with T2 comorbidities
ISAR ’s new publication "Association between T2-related co-morbidities and effectiveness of biologics in severe asthma” to the highly...
Mar 14, 20241 min read
Latest ISAR research reveals the significant impact of pre-existing health on response to treatment with biologics in Severe Asthma
Important progress has been gained in the journey towards understanding response to biologic therapy in severe asthma through the...
Feb 22, 20242 min read
Pioneering Study Reveals No Increased Pneumonia Risk in COPD Patients Using Extrafine Beclometasone Dipropionate in Inhaler Therapy
A ground-breaking study conducted by an international consortium of leading respiratory experts sheds new light on the management of COPD
Feb 21, 20242 min read
Observational and Pragmatic Research International Joins the Good Business Charter
Observational and Pragmatic Research International Limited is delighted to announce that it has signed up to the Good Business Charter (GBC)
Feb 2, 20243 min read
LANDMARK STUDY REVEALS ADVERSE OUTCOMES LINKED TO ORAL CORTICOSTEROID USE IN COPD PATIENTS
Singapore, [4 December 2023] - Results from a real-world research study have highlighted the risks associated with the long-term use of...
Dec 12, 20232 min read
New inventory of severe asthma registries unlocks potential for global research and best care
ISAR’s new publication ‘Adult severe asthma registries: a global and growing inventory’ to the journal Pragmatic and Observational...
Nov 6, 20231 min read
A greater number of comorbidities is associated with poorer outcomes among adults with severe asthma
The International Severe Asthma Registry (ISAR)’s newest study has determined comorbidities and multimorbidity to be frequent in adults with
Oct 18, 20231 min read
Opportunities to Optimize High-risk COPD Management Persist in US Primary Care
OPRI and affiliate organization, OPC announced the results of the latest observational study for CONQUEST
Aug 1, 20233 min read
Biologics dramatically reduce steroid requirements and exacerbation rates in severe asthma patients
The International Severe Asthma Registry (ISAR)’s newest study has found that keeping severe asthma patients on high oral corticosteroid...
Jul 25, 20231 min read
CONQUEST Shines Spotlight on Opportunities to Enhance Cardiopulmonary Outcomes Among High-risk COPD
This study demonstrated key areas to enhance care for exacerbating COPD patients to minimise the risk of future cardiopulmonary events.
Apr 26, 20233 min read
bottom of page